Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

Oncogene

Volumn 25, Issue 18, 2006, Pages 2679-2684

  Weniger, M A ^a   Melzner, I ^a   Menz, C K ^a   Wegener, S ^a   Bucur, A J ^a   Dorsch, K ^a   Mattfeldt, T ^a   Barth, T F E ^a   Moller P ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Hodgkin lymphoma; Primary mediastinal B cell lymphoma; SOCS 1; STAT5

Indexed keywords

DNA; JANUS KINASE 2; PHOSPHOPROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

AMINO ACID SEQUENCE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GENE MUTATION; GENE SILENCING; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; REED STERNBERG CELL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HODGKIN DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LASERS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; REED-STERNBERG CELLS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 33646382121     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209151     Document Type: Article

References (25)

1. Barth TF, Leithäuser F, Joos S, Bentz M, Möller P. (2002). Lancet Oncol 3: 229-234.
2. Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. (2003). Blood 101: 3681-3686.
3. Chen CY, Tsay W, Tang JL, Shen HL, Lin SW, Huang SY et al. (2003). Genes Chrom Cancer 37: 300-305.
4. Chim CS, Fung TK, Cheung WC, Liang R, Kwong YL. (2004a). Blood 103: 4630-4635.
5. Chim CS, Wong KY, Loong F, Srivastava G. (2004b). Leukemia 18: 356-358.
6. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K et al. (1997). Nature 387: 921-924.
7. Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG. (2003). Blood 101: 2784-2788.
8. Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P et al. (2004). Blood 104: 543-549.
9. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS et al. (1998). Proc Natl Acad Sci USA 95: 114-119.
10. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. (2005). Nature 434: 1144-1148.
11. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JL et al. (2003). Int J Cancer 103: 489-495.
12. Joos S, Otano-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M et al. (1996). Blood 87: 1571-1578.
13. Komazaki T, Nagai H, Emi M, Terada Y, Yabe A, Jin E et al. (2004). Jpn J Clin Oncol 34: 191-194.
14. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. (2005). N Engl J Med 352: 1744-1746.
15. Krebs DL, Hilton DJ. (2001). Stem Cells 19: 378-387.
16. Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I et al. (2001). Blood 98: 762-770.
17. Melzner I, Bucur AJ, Brüderlein S, Dorsch K, Hasel C, Barth TF et al. (2005). Blood 105: 2535-2542.
18. Melzner I, Weniger MA, Bucur AJ, Brüderlein S, Dorsch K, Hasel C et al. (2006). Int J Cancer 118: 1941-1944.
19. Ritz O, Leithäuser F, Hasel C, Brüderlein S, Ushmorov A, Möller P et al. (2005). J Pathol 205: 336-348.
20. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD et al. (2003). J Exp Med 198: 851-862.
21. Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH et al. (2002). Oncogene 21: 4351-4362.
22. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L et al. (2003). Blood 102: 3871-3879.
23. Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U et al. (2002). Blood 99: 618-626.
24. Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W et al. (2004). Oncogene 23: 7726-7733.
25. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE et al. (2001). Nat Gen 28: 29-35.